> top > docs > PubMed:32865072 > annotations

PubMed:32865072 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 419-426 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T2 419-426 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 419-426 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 0-9 Disease denotes Epistaxis http://purl.obolibrary.org/obo/MONDO_0005305
T2 40-48 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 62-71 Disease denotes epistaxis http://purl.obolibrary.org/obo/MONDO_0005305
T4 89-97 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 254-262 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 289-298 Disease denotes epistaxis http://purl.obolibrary.org/obo/MONDO_0005305
T7 620-629 Disease denotes epistaxis http://purl.obolibrary.org/obo/MONDO_0005305
T8 678-686 Disease denotes rhinitis http://purl.obolibrary.org/obo/MONDO_0003014

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 112-113 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 506-507 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 545-551 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T4 693-694 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 419-426 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T2 481-487 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 651-660 http://purl.obolibrary.org/obo/GO_0009058 denotes formation

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 0-9 Phenotype denotes Epistaxis http://purl.obolibrary.org/obo/HP_0000421
T2 62-71 Phenotype denotes epistaxis http://purl.obolibrary.org/obo/HP_0000421
T3 289-298 Phenotype denotes epistaxis http://purl.obolibrary.org/obo/HP_0000421
T4 620-629 Phenotype denotes epistaxis http://purl.obolibrary.org/obo/HP_0000421
T5 678-686 Phenotype denotes rhinitis http://purl.obolibrary.org/obo/HP_0012384

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 26-34 Species denotes patients Tax:9606
3 40-48 Disease denotes COVID-19 MESH:C000657245
13 75-83 Species denotes patients Tax:9606
14 89-97 Disease denotes COVID-19 MESH:C000657245
15 240-248 Species denotes patients Tax:9606
16 254-262 Disease denotes COVID-19 MESH:C000657245
17 380-388 Species denotes patients Tax:9606
18 419-426 Chemical denotes heparin MESH:D006493
19 481-487 Chemical denotes oxygen MESH:D010100
20 664-672 Species denotes patients Tax:9606
21 678-686 Disease denotes rhinitis MESH:D012220

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-49 Sentence denotes Epistaxis in hospitalized patients with COVID-19.
T2 50-206 Sentence denotes Spontaneous epistaxis in patients with COVID-19 can represent a clinical challenge with respect to both the risk of contamination and the treatment options.
T3 207-375 Sentence denotes We herein present the data of 30 patients with COVID-19 who developed spontaneous epistaxis while hospitalized at Eastern Piedmont Hospital during March and April 2020.
T4 376-561 Sentence denotes All patients received low-molecular-weight heparin during their hospital stay and required supplementary oxygen therapy either by a nasal cannula or continuous positive airway pressure.
T5 562-630 Sentence denotes Both conditions can represent risk factors for developing epistaxis.
T6 631-733 Sentence denotes Prevention of crust formation in patients with rhinitis using a nasal lubricant should be recommended.
T7 734-805 Sentence denotes If any treatment is required, appropriate self-protection is mandatory.